<- Go Home
Probiotec Limited
Probiotec Limited engages in the development, manufacture, packing, distribution, and sale of prescription and over the counter pharmaceuticals, complementary medicines and consumer health products, and fast-moving consumer products in Australia and internationally. The company provides contract manufacturing services for solid dose tablets, capsules, and caplets; tablets coatings; blister packs, bottles, sachets, tubs, and tubes; liquids, creams, gels, lotions, ointments, and powders and powder blends. It is also involved in analytical and stability testing services; new product formulation and production trials, and ongoing research and development services; and packaging options for human and animal nutrition products, as well as manufactures and exports a range of nutraceuticals and functional ingredient raw materials. The company was incorporated in 1996 and is headquartered in Laverton North, Australia. As of June 18, 2024, Probiotec Limited operates as a subsidiary of PYFA Australia Pty Ltd.
Market Cap
AUD 242.3M
Volume
56.2K
Cash and Equivalents
AUD 12.8M
EBITDA
AUD 27.2M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
AUD 66.3M
Profit Margin
29.95%
52 Week High
AUD 3.03
52 Week Low
AUD 2.13
Dividend
N/A
Price / Book Value
2.74
Price / Earnings
28.64
Price / Tangible Book Value
57.11
Enterprise Value
AUD 315.6M
Enterprise Value / EBITDA
9.38
Operating Income
AUD 19.0M
Return on Equity
10.18%
Return on Assets
5.09
Cash and Short Term Investments
AUD 12.8M
Debt
AUD 86.1M
Equity
AUD 88.3M
Revenue
AUD 221.2M
Unlevered FCF
AUD 5.4M
Sector
Pharmaceuticals
Category
N/A